Retinal microvascular function: a tractable biomarker of cardiovascular risk?
- PMID: 36310539
- DOI: 10.1093/cvr/cvac170
Retinal microvascular function: a tractable biomarker of cardiovascular risk?
Conflict of interest statement
Conflict of interest: The authors are employed by the University of Glasgow, which holds consultancy and research agreements with companies that have commercial interests in the diagnosis and management of angina, including Abbott Vascular, AstraZeneca, Boehringer Ingelheim, GSK, Heartflow, Menarini Pharmaceuticals, Neovasc, Siemens Healthcare and Valo Health. The authors received no support from any of these organizations for the submitted work.
Comment on
-
Mortality prediction of retinal vessel diameters and function in a long-term follow-up of haemodialysis patients.Cardiovasc Res. 2022 Dec 29;118(16):3239-3249. doi: 10.1093/cvr/cvac073. Cardiovasc Res. 2022. PMID: 35576475

